Ipamorelin Stacking and Combinations
Which compounds Ipamorelin is paired with, and the rationale behind each combination.
Common Pairings
Ipamorelin is most often stacked with CJC-1295 (DAC). Pairing compounds that act through complementary pathways can broaden the effect without simply doubling one mechanism. Introduce a stack one compound at a time so you can attribute any change, and keep the total load conservative.
Stacking Principles
As a rule, more compounds is not better. Each addition adds cost, injection burden, and another variable to untangle if something feels off. Ask REGEN AI to sanity-check any stack against your goals and bloodwork before you start.
Commonly paired with
- CJC-1295 (DAC) — The long-acting form of CJC-1295: a DAC tag extends its half-life to days for a sustained growth hormone bleed.
- Tesamorelin — An FDA-approved GHRH analog known for reducing stubborn visceral fat and raising IGF-1 levels.
- CJC-1295 (no-DAC) — The short-acting form of CJC-1295 (Mod GRF 1-29): a sharp, pulsatile GH release that closely mimics natural rhythm.
- MK-677 — An oral ghrelin-receptor agonist that raises growth hormone and IGF-1 around the clock without injections.
- Sermorelin — A classic 29-amino-acid GHRH fragment, historically FDA-approved as Geref — clears fast, keeping GH release in its natural pulsatile rhythm.
References
- Ipamorelin, the first selective growth hormone secretagogue · Raun K, et al. · 1998
- Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients. · Beck DE, Sweeney WB, McCarter MD et al. · 2014
- Ipamorelin | C38H49N9O5 | CID 9831659 - PubChem - NIH
- Hansen BS, et al. The growth hormone secretagogue ipamorelin: pharmacological profile. Endocrinology. 1999;140(11):5552-5561. · Cowen ME, Miles BJ, Cahill DF, Giesler RB, Beck JR, Kattan MW · 1998
- Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers. · Gobburu JV, Agersø H, Jusko WJ et al. · 1999
- Johansen PB, et al. Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats. Growth Hormone & IGF Research. 1999;9(2):106-113. · Johansen PB, Nowak J, Skjaerbaek C, Flyvbjerg A, Andreassen TT, Wilken M, Orskov H · 1999